$6.81
0.507.92%
Últ. Act.: Oct 29, 5:06 PM
Evommune (EVMN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.67 | $-0.84 | $-0.75 | — |
| Actual | $-0.89 | $-0.64 | $-1.43 | $-8.07 |
| Surprise | -32.8% | +23.8% | -90.7% | — |
| Revenue | ||||
| Estimate | $1.4M | $1.3M | $6.0M | — |
| Actual | $0 | $0 | $0 | $10000 |
| Surprise | -100.0% | -100.0% | -100.0% | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.83 | $-0.90 | $-0.97 | $-1.00 |
| Revenue | ||||
| Consensus | $600000 | $400000 | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.89 | $-0.67 | -32.8 % |
| Q1 | May 7, 2026 | $-0.64 | $-0.84 | 23.8 % |
| Q4 | Mar 5, 2026 | $-1.43 | $-0.75 | -90.7 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0 | $1.40M | -100.0 % |
| Q1 | May 7, 2026 | $0 | $1.30M | -100.0 % |
| Q4 | Mar 5, 2026 | $0 | $6.00M | -100.0 % |